Sterling Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, to review, consider and adopt the Unaudited Financial Results for the period ended on December 31, 2016, along with the Limited Review Report of the Statutory Auditor thereon.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed that the Company was following a Calendar Year as the accounting year till December, 2014. The Company had at the last Annual General Meeting held on June 30, 2015 passed the special resolution for change in financial year from December to March in compliance of the Companies Act, 2013. The next financial year of the Company will be for fifteen months i.e. from January 01, 2015 to March 31, 2016.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed about the details of voting results at the Annual General Meeting (AGM) of the Company held on June 30, 2015, under Clause 35A.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed that the 28th Annual General Meeting (AGM) of the Company was held on June 30, 2015.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed about formulation and adoption of Codes under SEBI (Prohibition of Insider Trading) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech about the Standalone Financial Results & a copy of the Auditors Report for the period ended December 31, 2014.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed that the 28th Annual General Meeting (AGM) of the Company was held on June 30, 2014.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed that the Register of Members & Share Transfer Books of the Company will remain closed from June 24, 2014 to June 30, 2014 for the purpose of 28th Annual General Meeting (AGM) of the company to be held on June 30, 2014. The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed about the Financial Results & a copy of the Limited Review Report for the period ended March 31, 2014.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech has informed about the Financial Results & a copy of the Auditors Report for the period ended December 31, 2013.The above information is a part of company’s filings submitted to BSE.

Sterling Biotech is currently trading at Rs. 9.65, up by 0.76 points or 8.89% from its previous closing of Rs. 8.89 on the BSE.The scrip opened at Rs. 9.49 and has touched a high and low of Rs. 9.74 and Rs. 9.04 respectively. So far 1, 07,000 shares were traded on the counter.The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 8.89 on 21-Nov-2013 and a 52 week low of Rs. 3.43 on 20-Mar-2013.Last one week high and low of the scrip stood at Rs. 8.89 and Rs. 5.06 respectively. The current market cap of the company is Rs. 259 crore.The promoters holding in the company stood at 33.91% while Institutions and Non-Institutions held 9.10% and 40.12% respectively.Sterling Biotech’s existing Bond Holders at its meeting held on November 20, 2013, have approved for the conversion price of the Bonds, due 2018 to be at Rs. 60 per share, subject to Reserve Bank of India, Foreign Investment Promotion Board and such other regulatory approvals, if any, as may be required; The Bond holders have also approved to suspend all litigations in India and UK till January 2014 and to withdraw the litigations in India and UK on completion of the exchange and substitution of the Existing Bonds with and for the Zero Coupon Convertible Bonds due 2018.Sterling Biotech is largest producer of pharmaceutical and nutraceutical gelatin in India and Asia as well. It has a 9.3% global market share in pharmaceutical gelatin and is among the top five gelatin producers globally.

Sterling Biotech is currently trading at Rs 8.26, up by 0.85 points or 11.47% from its previous closing of Rs 7.41 on the BSE.The scrip opened at Rs 8.50 and has touched a high and low of Rs 8.89 and Rs 7.60 respectively. So far 2481451 shares were traded on the counter.The BSE group 'B' stock of face value Re 1 has touched a 52 week high of Rs 8.20 on 09-Jan-2013 and a 52 week low of Rs 3.43 on 20-Mar-2013.Last one week high and low of the scrip stood at Rs 7.41 and Rs 5.06 respectively. The current market cap of the company is Rs. 221.26 crore.The promoters holding in the company stood at 33.91% while Institutions and Non-Institutions held 9.10% and 40.12% respectively.Sterling Biotech’s existing Bond Holders at its meeting held on November 20, 2013, have approved for the conversion price of the Bonds, due 2018 to be at Rs. 60 per share, subject to Reserve Bank of India, Foreign Investment Promotion Board and such other regulatory approvals, if any, as may be required; The Bond holders have also approved to suspend all litigations in India and UK till January 2014 and to withdraw the litigations in India and UK on completion of the exchange and substitution of the Existing Bonds with and for the Zero Coupon Convertible Bonds due 2018.Sterling Biotech is largest producer of pharmaceutical and nutraceutical gelatin in India and Asia as well. It has a 9.3% global market share in pharmaceutical gelatin and is among the top five gelatin producers globally.